Objectives. In this study we aimed to investigate causes of hyperparathyroidism and related factors in postmenopausal women. Methods. The study was conducted on 156 postmenopausal women, 43 with normal serum parathyroid hormone (PTH) levels and 113 with elevated serum PTH levels. Serum levels of 25-OH vitamin D, calcium and phosphorus, 24-hour urine calcium, phosphorus and calcium/creatinine ratio were compared between study groups. Also, bone mineral density, age of menopause, educational level, occupation, clothing style, daylight exposure time and daily dietary calcium consumption of subjects and relationships of these parameters with parathyroid hormone levels were investigated. Results. Causes of elevated serum PTH level were vitamin D deficiency in 92.9% and primary hyperparathyroidism in 4.4% of study group. Serum PTH levels were significantly higher in housewives (p<0.001), women with less than a high school graduates (p=0.008), and the veiled women (p=0.025). Serum 25-OH vitamin D levels were significantly lower in the veiled covered (p=0.002) and participants with less than a high school graduate (p=0.041). Significant negative correlation was detected between serum 25-OH vitamin D and the logarithmic value of serum PTH levels (r= -0.188; p=0.019). Conclusions. Vitamin D deficiency was common in all postmenopausal women but especially in those with lower education level and the veiled. Postmenopausal women should be screened for vitamin D deficiency and encouraged to benefit more from sunlight. Also, enriching foods in the markets with vitamin D may be helpful for decreasing hyperparathyroidism in this population.
Introduction
Primary hyperparathyroidism is a calcium metabolism disorder characterized by excessive production of parathyroid hormone (PTH) from the parathyroid glands without any stimulus known or described. Primary hyperparathyroidism affects 0.3% of the general population and 2.1% of the postmenopausal women [1] . Secondary hyperparathyroidism is described as increased secretion of PTH as a result of the stimulation of the calcium sensitive receptors secondary to a decrease in serum calcium level. Secondary hyperparathyroidism affects 1% of the general population and is usually secondary to low oral intake of calcium and/or vitamin D deficiency [2] . Secondary hyperparathyroidism secondary to vitamin D deficiency leads to mineralization disorders of the bones, low bone mineral density, osteoporosis and ultimately an increased risk of bone fracture in adults [3] . Calcium and vitamin D replacement leads to reduction in fracture incidence in elderly people but treatment with only vitamin D does not provide significant benefits [4] .
In this study, we screened the etiologies of elevated PTH levels in postmenopausal women without concomitant diseases or use of drugs that may interfere with PTH levels. Also, we aimed to determine the incidence of clinically asymptomatic primary hyperparathyroidism, the causes of secondary hyperparathyroidism, social risk factors of hyperparathyroidism and the measures that can be taken to avoid hyperparathyroidism and its complications in postmenopausal women.
Methods
One hunded and fifty-six postmenopausal women, 113 with elevated PTH levels and 43 with normal PTH levels, admitted to the department of Internal Medicine outpatient clinics of Uludag University Hospital (from October 2010 to May 2011), aged ≥50 years, had no menstruation for at least two years and no disease to affect calcium metabolism were included. Premenopausal women aged <50 years, postmenopausal women aged ≥75 years, women with a previous diagnosis of parathyroid gland disease, chronic renal failure, malabsorption, biphosphonate, thiazid or corticosteroid drug use and acute infection were excluded. Serum PTH levels higher than 68.3 pg/ml was considered as hyperparathyroidism according to Uludag University Laboratory parameters. The study protocol was approved by Medical Research Ethics Committee of Uludag University (Date: 28.09.2010; Nr: 2010-9/15) and written informed consent were taken from all patients included to the study.
Education, occupation, average duration of exposure to sunlight per day during summer and winter, consumption of calcium-rich foods were recorded. Participants were divided into four groups according to their educational levels: had no formal education, primary school, high school and college graduates; two groups according to their clothings: veiled and non-veiled; three groups according to their occupational status as housewives, workers and retired people; two groups according to sunlight exposure insufficient (less than 20 minutes per day) and sufficient (more than 20 minutes per day); two groups according to daily calcium consumption adequate and inadequate. Daily calcium intake of subjects were calculated by using a questionnaire form which prepared by Turkish Dietitians' Association. The questionnare form was designed to assessment calcium content of dietary records.
Venous blood samples were collected after 10-hours of overnight fast and centrifuged. Levels of calcium, phosphorus, creatinine, alkaline phosphates, albumin and follicle stimulating hormone (FSH) were determined using commercially available assay kits with an Abbott Architect C16000 auto-analyzer. PTH levels were measured using Abbott G200 kits with an Abbott Architect i2000sr analyzer. 25-OH vitamin D levels were measured using THERMO HPLC analyzer. 24-hour urinary calcium, phosphorus and creatinine excretion were measured. Patients with high serum creatinine levels and FSH levels lower than 20 IU/ml were excluded from the study.
Bone mineral density measurements in all participants were detected by dual-energy x-ray absorptiometry (DEXA) method using with Hologic QDR-4500A S/N 45130 analyzer (Hologic Inc. Bedford, MA, USA). The measurements of the lumbar spine and the left femur were recorded. The mineral density (g/cm²) of the second lumbar (L) vertebra and the average mineral density of the L 1-4 vertebrae were compared statistically. Also the mineral density (g/cm²) of the left femoral neck and the average mineral density of the femoral neck, trochanteric and intertrochanteric regions were compared.
Statistical Analysis
Continuous variables were expressed as mean ± standard error, median, minimum and maximum values. Categorical variables were expressed as number and percentage values. The suitability of the normal distribution of continuous variables was analyzed by Shapiro Wilk test. According to the test results, in cases where there is compliance with the normal distribution, independent-samples t test was used for between groups comparisons. Correlation analysis was used for determination the relationship between continuous variables and Pearson correlation coefficient was calculated. 
Results
The mean age was 56.9 (range; 50-74) years in patients (n=113) with hyperparathyroidism and 57.9 (range; 50-72) years in the control group (n=43). There were no significant differences between the groups in terms of menopausal age, body mass index, serum calcium levels and serum 25-OH vitamin D levels but serum phosphorus levels were significantly lower in the study group (Table1). 24-hour urinary calcium excretion (24hUca) was reduced in the study group and 24-hour urinary phosphorus (24hUp) excretion was similar in both groups (Table1). Creatinine clearance was 110.6±2.2 ml/min in control study group and 108±3.5 ml/min in control group which was not statistically significant (p=0.530). 24hUca was 132.3±7.3 mg/24h in study group and 168.5±11.8 mg/24h in control group which was statistically significant (p=0.006). Tubular phosphorus reabsorption (TRp) was 86.0±0.4% in study group and 86.7±0.6% in control group, which was not statistically significant (p=0.478). Urinary calcium- creatinine ratio (Uca/Ucr) was 0.009±0.004 in study group and 0.012±0.004 in control group which was statistically significant (p=0.001) ( Table 1 ). Significant negative correlation were detected between logarithmic values of serum PTH levels and serum 25-OH vitamin D levels of both groups (r= -0.188; p=0.019) (Figure 1 ) but correlation coefficient was low showing a weak correlation.
There was no statistically significant difference between groups in terms of bone mineral density (Table 2) . However, the mean mineral density of the L 1-4 vertebrae were in negative corerelation with the increase in serum PTH levels which was statistically significant (r= -0.175; p=0.029) despite this significance correlation coefficient was low showing a weak correlation, similarly the mean mineral density of the femoral neck, wards triangle and trochanteric region did not show any correlation.
Based on our data, serum PTH levels were significantly higher in housewives (p<0.001), women with less than a high school graduates (p=0.008), and the veiled women (p=0.025). Living alone and smoking were found to have no effect on serum PTH levels. PTH levels were not significantly different between groups with adequate calcium consumption and inadequate calcium consumption and also PTH levels were significantly different between groups with insufficient sunlight exposure and sufficient sunlight exposure (Tables 3 and 4) .
Serum 25-OH vitamin D levels were significantly lower in the veiled covered (p=0.002); in participants with less than a high school graduate (p=0.041). Living alone, being a housewife or retired, smoking, sunlight exposure, calcium consumption found to have no effect on serum vitamin D levels (Table 5) .
When the causes of elevated serum PTH levels were examined, 25-OH vitamin D deficiency was detected in 105 of cases and primary hyperparathyroidism was detected in five cases with 25-OH vitamin D deficiency (Table 6 ).
Discussion
Causes of elevated serum PTH levels are adenoma, hyperplasia and carcinoma of the parathyroid gland. Elevated PTH levels may be a physiological response which is called secondary hyperparathyroidism especially seen in cases with low serum calcium levels. Decreased oral intake or intestinal absorption of calcium, vitamin D deficiency, 238 # # increased renal calcium losses, impaired renal function results in elevated serum PTH levels. In our study, serum calcium levels were not statistically different between the study group and the control group but 24-hour urine calcium excretion was significantly lower in the study group. It was understood that vitamin D deficiency was the most important reason for this situation Reduction of renal phosphorus reabsorption is expected in vitamin D deficiency depending on the decreased intestinal absorption of phosphorus and the increased PTH activity leading to a decrease in serum phosphorus level. The levels of serum phosphorus were significantly lower in the study group than the control group. These results are expected in vitamin D deficiency. Although statistically significant reduction of the calculated rate of tubular reabsorption was not detected. Serum 25-OH vitamin D levels were low in both control and study groups. A negative correlation was detected between serum PTH levels and 25-OH vitamin D levels. However, PTH levels were not increased in the control group with low 25-OH vitamin D levels Albertazzi et al. [5] divided the subjects in their study according to the levels of serum PTH and observed that serum 25-OH vitamin D levels were significantly lower in the group with high serum PTH levels. Sahota et al. [6] reported that vitamin D deficiency was common in active elderly people living at home but they also reported that secondary hyperparathyroidism was not so common among these elderly.
In other studies, secondary hyperparathyroidism was observed in approximately only 30-50% of elderly people with low serum 25-OH vitamin D levels [7] . There may be several reasons for this situation. PTH levels may not be increased in people with vitamin D deficiency that consumes calcium-rich foods [8] . There may be personal differences in terms of intestinal calcium absorption, even if there is not a consumption of calcium-rich foods [9] . Also, the measured serum vitamin D is 25-OH vitamin D which is a reliable method in terms of showing the levels of stored vitamin D. However, the effect of serum PTH levels on [1.25(OH)2D], which is active vitamin D, is not clear [10] .
One of the main problems encountered with increased levels of serum PTH is decrease in bone mineral density in long term. Decrease in bone mineral density is seen not only in hypercalcemic patients with primary hyperparathyroidism and also seen in normocalcemic patients with primary hyperparathyroidism [1] . Renjmark et al's [11] study showed that bone mineral density was lower especially in the femoral neck and the risk of osteoporotic bone fracture was 59% in normocalcemic patients with hyperparathyroidism. Decrease in bone mineral density was seen not only in patients with primary hyperparathyroidism and also seen in patients with secondary hyperparathyroidism due to vitamin D deficiency. Nakamura et al. [12] showed a significant decrease in bone mineral density in patients with hyperparathyroidism but they also showed a decrease in bone mineral density in patients with vitamin D deficiency independently from PTH levels. There are no adequate data about what levels of increase in serum PTH may adversely affect bone mineral density [13] . Albettazzi et al. [5] compared the cases with elevated serum PTH levels and with normal serum PTH levels in their study but they could not detect a significant relationship between serum PTH levels and the bone mineral density of the lumbar spine and the femoral neck. Similarly, Kaya et al. [14] found no association between bone mineral density and elevated serum PTH levels in their study. But Silverberg et al. [15] demonstrated slightly decrease in bone mineral density with elevated PTH levels in their study. In our study, there is no significant difference between the study and control group in terms of bone mineral density and it may be related to the duration of hyperparathyroidism. Our study was a cross-sectional study and we did not know how long the patients had hyperparathyroidism. Probably, due to short-term exposure of elevated PTH levels and the small number of the study group, a significant difference could not be identified between the two groups in terms of bone mineral density. In addition, the levels of vitamin D deficiency in both groups were not very different. Therefore, it is considered that the levels of secondary hyperparathyroidism, the main factor that causes bone resorption, were not at the levels of negative effect on bone mineral density.
The reduction of bone mineral density is usually detected in all of the measurement regions in patients with primary hyperparathyroidism [16] . However, increase in bone resorption due to hyperparathyroidism is expected in cortical bones [15, 17] . Proximal radius is the region with highest cortical bone. In our study, due to the fact that the bone mineral densities of the lumbar vertebra, which is mainly trabecular, and femur, which is mainly cortical, were measured and the bone mineral density of proximal radius was not measured, a significant difference could not be identified in patients with hyperparathyroidism.
Vitamin D deficiency/insufficiency is one of the most discussed topics. What should be the normal range of serum 25-OH vitamin D levels are not exactly certain for the definition of vitamin D deficiency. The level that stimulates parathyroid gland for PTH secretion is generally accepted as cut off for vitamin D deficiency [18] . In 1985, Peacock et al. [19] defined vitamin D insufficiency in addition to vitamin D deficiency. They proposed to define serum vitamin D level less than 10 ng/ml as deficiency and serum vitamin D level less than 20 ng/ml as insufficiency. The minimum level of serum 25-OH vitamin D necessary to normalize the increased bone turnover due to elevated serum PTH was 20 ng/ml (80 mmol/l) [20, 21] . Generally, serum vitamin D level less than 20 ng/ml is defined as deficiency and serum vitamin D level less than 30 ng/ml is defined as insufficiency [15, [22] [23] [24] . In a study performed in our country, sufficient serum 25-OH vitamin D levels were observed in only 18% of postmenopausal women and elderly men. In addition, there was no relationship between the levels of serum 25-OH vitamin D and some parameters such as serum PTH levels, age, body mass index and dietary calcium content [25] . 25-OH vitamin D level less than 20 ng/ml was defined as vitamin D deficiency in our study. We detected sufficient serum 25-OH vitamin D levels in only eight patients (7.4%) with hyperparathyroidism and in only six patients (13.9%) without hyperparathyroidism.
The frequency of vitamin D deficiency was detected as 50-97% in several studies in different populations [26, 27] . This increased incidence was not only reported in countries with insufficient exposure to sunlight Vitamin D deficiency is detected up to 90% in countries such as Greece, Italy and Spain during winter [28] . The different results detected in the studies were thought to be associated with the habits of vitamin D-rich food consumption and the use of drugs containing vitamin D. In many studies synthesis of vitamin D has been shown to be decreased with increasing age [29, 30] . Therefore, the daily requirement of vitamin D is known to be increased in advanced age. In patients requiring vitamin D supplementation, daily 400 units of vitamin D supplementation is considered insufficient and it is accepted that this dosage should be increased to 800 units/day. Apart from all these, the reason for the detection of extremely low serum 25-OH vitamin D levels may be related to the adequacy of the study method. It was shown in studies that there may be significant differences between the assays used in the measurements of serum 25-OH vitamin D levels and also significant deviations were found between the measurements performed in different laboratories, although the same study method [31, 32] . HPLC (Recipe ®) method was used for the measurement of vitamin D in our study. It is a very reliable method with 2.7% intraassay deviation and 3.7% interassay deviation. In some studies, HPLC method has been reported to be more sensitive than chemiluminescent immunoassay or radio immunoassay methods [33] .
In our study, participants were divided into groups based on various social features. Participants were mainly composed of people with hyperparathyroidism. The control group were only 27.5% of all participants. In our society, the most important factors leading to vitamin D deficiency were being veiled and having low levels of education. Since, living alone, being housewife or retired, smoking, sunlight exposure, calcium consumption found to have no effect on serum vitamin D levels Our study proved once more that vitamin D deficiency is the most important cause of hyperparathyroidism.
The incidence of primary hyperparathyroidism was calculated as 4.4% in our study group. It was a very high prevalence although the average age of the group was not very advanced. In comprehensive studies, the prevalence of primary hyperparathyroidism ranged from 3/1000 to 21/1000. However, in our study, patients with elevated levels of serum PTH were selected and there were sufficient numbers of patients as a control group. Therefore, the frequency of detected primary hyperparathyroidism reflected primary hyperparathyroidism frequency of patients with elevated PTH levels rather than primary hyperparathyroidism frequency of general population. Primary hyperparathyroidism was detected in 5 cases. The remaining 108 patients had elevated serum PTH levels but normal serum calcium levels. After vitamin D deficiency, calcium renal leak, and hypocalciuric hypercalcemia excluded; we evaluated 4 patients (3.5%) as normocalcemic with hyperparathyroidism. In studies on long-term follow-up these patients, it has been shown that the possibility of hypercalcemic hyperparathyroidism development was very low [1] . Some studies reported that there may be adverse effects on bone mineral density in these cases [34] .
